Targeted Therapy Directed by Genetic Testing in Treating Patients With Advanced Refractory Solid Tumors, Lymphomas, or Multiple Myeloma (The MATCH Screening Trial)
National Cancer Institute (NCI)
National Cancer Institute (NCI)
Jazz Pharmaceuticals
National Institutes of Health Clinical Center (CC)
Convalife (Shanghai) Co., Ltd.
University of California, Irvine
Daiichi Sankyo
ImmunityBio, Inc.
University of Pittsburgh
Telix Pharmaceuticals (Innovations) Pty Limited
Apollomics Inc.
University of California, Irvine
Azienda USL Reggio Emilia - IRCCS
Tongji Hospital
Rain Oncology Inc
Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University
Erasmus Medical Center
Universitair Ziekenhuis Brussel
Convalife (Shanghai) Co., Ltd.
pharmaand GmbH
Ellipses Pharma
Union Hospital, Tongji Medical College, Huazhong University of Science and Technology
Kyunghee University Medical Center
MultiVir, Inc.
Eli Lilly and Company
Wake Forest University Health Sciences
Roswell Park Cancer Institute
Cornerstone Pharmaceuticals
National University Hospital, Singapore
Roger Williams Medical Center
National Cancer Institute (NCI)
M.D. Anderson Cancer Center
Georgetown University
The University of Texas Health Science Center, Houston
Wuhan University
National Institutes of Health Clinical Center (CC)
Adherex Technologies, Inc.